L-Arginine is a precursor of polyamine, nitric oxide (NO), creatine, and agmatine and is essential for the differentiation and proliferation of blood cells, although the precise biological role of L-arginine is unclear. We have recently reported that the depletion of L-arginine in cultured medium prevented both proliferation and differentiation of blood cells (Shima et al., Blood First Edition Paper, October 6, 2005; DOI 10.1182). Since one of metabolic products of L-arginine in the cells is polyamine that associates with cell differentiation and proliferation, the effects of L-arginine on the human K562 cell line and human cord blood-derived CD34 positive cells were investigated by focusing on polyamines such as putrescine, spermidine, and spermine in the present study. When polyamines were added to the culture medium in the absence of L-arginine, the cells did not grow or differentiate well. However, when intracellular polyamines were depleted using ornithine decarboxylase inhibitor, alpha-difluoromethylornithine (DFMO), the proliferation and differentiation of K562 cells to erythrocytes were reduced even in the presence of L-arginine. Moreover, in the presence of DFMO, cell differentiation and proliferation were recovered by the addition of putrescine or spermidine in the presence of L-arginine. Accordingly, it was demonstrated that polyamines are essential for the proliferation and differentiation of the blood cells as the metabolites of L-arginine and the externally added polyamines are also effective by being taken up through polyamine transporter.

Consensus recommendations for risk stratification in multiple myeloma: report of the International Myeloma Workshop Consensus Panel 2 / Munshi N.C.; Anderson K.C.; Bergsagel P.L.; Shaughnessy J.; Palumbo A.; Durie B.; Fonseca R.; Stewart A.K.; Harousseau J.L.; Dimopoulos M.; Jagannath S.; Hajek R.; Sezer O.; Kyle R.; Sonneveld P.; Cavo M.; Rajkumar S.V.; San Miguel J.; Crowley J.; Avet-Loiseau H.; International Myeloma Workshop Consensus Panel 2.. - In: BLOOD. - ISSN 0006-4971. - STAMPA. - 117:18(2011), pp. 4696-4700. [10.1182/blood-2010-10-300970]

Consensus recommendations for risk stratification in multiple myeloma: report of the International Myeloma Workshop Consensus Panel 2

CAVO, MICHELE;
2011

Abstract

L-Arginine is a precursor of polyamine, nitric oxide (NO), creatine, and agmatine and is essential for the differentiation and proliferation of blood cells, although the precise biological role of L-arginine is unclear. We have recently reported that the depletion of L-arginine in cultured medium prevented both proliferation and differentiation of blood cells (Shima et al., Blood First Edition Paper, October 6, 2005; DOI 10.1182). Since one of metabolic products of L-arginine in the cells is polyamine that associates with cell differentiation and proliferation, the effects of L-arginine on the human K562 cell line and human cord blood-derived CD34 positive cells were investigated by focusing on polyamines such as putrescine, spermidine, and spermine in the present study. When polyamines were added to the culture medium in the absence of L-arginine, the cells did not grow or differentiate well. However, when intracellular polyamines were depleted using ornithine decarboxylase inhibitor, alpha-difluoromethylornithine (DFMO), the proliferation and differentiation of K562 cells to erythrocytes were reduced even in the presence of L-arginine. Moreover, in the presence of DFMO, cell differentiation and proliferation were recovered by the addition of putrescine or spermidine in the presence of L-arginine. Accordingly, it was demonstrated that polyamines are essential for the proliferation and differentiation of the blood cells as the metabolites of L-arginine and the externally added polyamines are also effective by being taken up through polyamine transporter.
2011
Consensus recommendations for risk stratification in multiple myeloma: report of the International Myeloma Workshop Consensus Panel 2 / Munshi N.C.; Anderson K.C.; Bergsagel P.L.; Shaughnessy J.; Palumbo A.; Durie B.; Fonseca R.; Stewart A.K.; Harousseau J.L.; Dimopoulos M.; Jagannath S.; Hajek R.; Sezer O.; Kyle R.; Sonneveld P.; Cavo M.; Rajkumar S.V.; San Miguel J.; Crowley J.; Avet-Loiseau H.; International Myeloma Workshop Consensus Panel 2.. - In: BLOOD. - ISSN 0006-4971. - STAMPA. - 117:18(2011), pp. 4696-4700. [10.1182/blood-2010-10-300970]
Munshi N.C.; Anderson K.C.; Bergsagel P.L.; Shaughnessy J.; Palumbo A.; Durie B.; Fonseca R.; Stewart A.K.; Harousseau J.L.; Dimopoulos M.; Jagannath S.; Hajek R.; Sezer O.; Kyle R.; Sonneveld P.; Cavo M.; Rajkumar S.V.; San Miguel J.; Crowley J.; Avet-Loiseau H.; International Myeloma Workshop Consensus Panel 2.
File in questo prodotto:
Eventuali allegati, non sono esposti

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11585/113659
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 116
  • Scopus 283
  • ???jsp.display-item.citation.isi??? 251
social impact